Jill Waldner

Vice President, Corporate Strategy And Development at Evidation Health

Jill Waldner has a diverse work experience spanning across various roles and organizations. Jill is currently serving as the Vice President of Corporate Strategy and Development at Evidation Health since July 2021. Prior to this, in January 2021, they became a Member of the Board of Trustees at The Children's Museum of Indianapolis.

Jill has also had a long tenure at Eli Lilly and Company, where they held multiple leadership positions. From January 2020 to June 2021, they served in a Field Sales Leadership role. Before that, as the Associate Vice President of Global Diabetes Manufacturing from January 2018 to December 2019, they played a key role in the company's global diabetes manufacturing operations. Jill has also worked as a Senior Director of Corporate Strategy, Director of Strategy for Delivery and Device Research and Development, Director and COO of Emerging Markets Access Expansion, and Strategy Director of Global Parenteral Product and Device Manufacturing at Eli Lilly.

Additionally, Jill has demonstrated their commitment to community engagement by serving as a Board Member and Capital Campaign Chair at the YMCA of Greater Indianapolis from January 2017 to December 2020.

Overall, Jill Waldner's work experience reflects their expertise in corporate strategy and development, leadership roles in the pharmaceutical industry, and their dedication to community organizations.

Jill Waldner attended Miami University from 1998 to 2002 and earned a Bachelor of Science (BS) degree in Business with a focus on Finance and Economics.

Links

Timeline

  • Vice President, Corporate Strategy And Development

    July, 2021 - present

View in org chart